Antibody prevents virus reactivation within the central nervous system.
about
De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous systemThe pathogenesis of murine coronavirus infection of the central nervous system.Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.Pathogenesis of murine coronavirus in the central nervous system.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.Factors supporting intrathecal humoral responses following viral encephalomyelitis.Control of central nervous system viral persistence by neutralizing antibody.CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis.Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitisCXCR2 signaling and host defense following coronavirus-induced encephalomyelitis.The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelinationRecruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.Antibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelinationPerforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cellsIL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis.Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous SystemExpression of cellular oncogene Bcl-xL prevents coronavirus-induced cell death and converts acute infection to persistent infection in progenitor rat oligodendrocytesMurine coronavirus neuropathogenesis: determinants of virulence.MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus.An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation.Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis.Distinct CD4 T-cell effects on primary versus recall CD8 T-cell responses during viral encephalomyelitis.Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis.Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
P2860
Q33610108-176156FC-4823-4F3D-948C-462DA3915DB8Q33779927-1A9FD9F2-DAC9-432B-88D5-3897392D0047Q33798574-ED835C23-4E3D-4857-85F3-5DE6D83E707CQ33883823-554DBB14-9997-49EC-858A-1712C3510319Q34039962-C6540D09-B429-420D-A233-B4F5E237FBBFQ34193942-9F9067A7-B80B-4138-9BE5-3CF0BB8863DFQ34225964-1FB68B3D-0734-47D2-BBB4-0B73CAADED11Q34742821-ABAE2222-A0B7-4229-9E99-C0C27317F441Q34859605-C630B2C5-1213-41FC-8EB0-A5418C2F38D0Q35077540-9283B839-B5CA-4310-91D2-869EF63F4504Q35088074-5CD75F52-9408-4139-9F1A-384D6B5BBEF5Q35543665-4356FA3D-DE37-49F4-BA27-14326ABE375AQ35826089-7203617C-5592-4584-975D-D56EB2F42BA1Q35947646-8B9E5C99-DCED-467A-A537-2401C418179DQ36468266-97D02DE6-15B5-4D56-9572-539B5300DA8FQ36484099-974B3AD5-BDF1-48F2-B936-2DDDFB0142E9Q36584434-783AD2CC-6F39-403B-9174-F91D100F5ED7Q36607157-2811A469-A721-4FC2-9EC1-62C188054EABQ36667911-D07D839F-5F0E-4B4C-8757-7F7937D5C223Q36890391-3D536F7F-C0D7-4EFB-A0F6-45B4D6897D55Q36961739-3A330194-BB20-4FB4-851D-2A927F6EBBCEQ37228165-D9F25EFE-6861-487D-90D4-825DF192DC79Q37259926-EB5B78A1-9A5A-4E86-A180-AFACFF2B9F1DQ37436632-BE23BD21-54F3-4637-B73A-4F9515470C73Q37747708-5AE864F8-74CB-4DE1-A889-F9611CCC5542Q37809054-FFE37058-520C-4806-8DB7-63BC7B5ED9F7Q38831191-DDA20053-86CE-4339-8A5F-7E6E513ADF4CQ40204989-3585BADA-F80F-426F-A8B0-F504B22F0DF9Q40530656-7D0595D6-6E67-42C6-B0C2-DB1C37DE8C22Q41754781-1928EBE8-9DAC-4390-A384-06B4C6EC2092Q41933450-DD5EE84A-294C-4860-9B59-69D1392669FCQ42260800-049CE6FC-A47A-4286-B8DE-3B00C59B901B
P2860
Antibody prevents virus reactivation within the central nervous system.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Antibody prevents virus reactivation within the central nervous system.
@en
type
label
Antibody prevents virus reactivation within the central nervous system.
@en
prefLabel
Antibody prevents virus reactivation within the central nervous system.
@en
P2093
P1476
Antibody prevents virus reactivation within the central nervous system.
@en
P2093
P304
P407
P577
1999-06-01T00:00:00Z